Germline ATRIP variants and the risk of ovarian cancer

Genetics in Medicine · Published 2026-05-01 · DOI 10.1016/j.gim.2026.102547

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.gim.2026.102547

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Mitochondrial aminoacyl-tRNA synthetase (ARS)-defects: A review of phenotypes and therapeutic strategies in 899 patients · Genetics in Medicine · 2026 · Same journal
• Genomics to enhance newborn screening? · Genetics in Medicine · 2026 · Same journal
• The Evidence Aggregator: AI reasoning applied to rare disease diagnostics · Genetics in Medicine · 2026 · Same journal
• Indigenous perspectives on biobanking, specimen storage, and data governance: A scoping review · Genetics in Medicine · 2026 · Same journal
• Familial Risk Stratification Across Cancer Syndromes Using Fam3PRO · Genetics in Medicine · 2026 · Same journal
• RNU4ATAC-opathy: Clinical, molecular, and transcriptomic insights from a large cohort · Genetics in Medicine · 2026 · Same journal
• New genotype-phenotype correlations and management recommendations for individuals with RERE variants · Genetics in Medicine · 2026 · Same journal
• Beyond mistrust: Diverse biobanking preferences among parents and adolescents with sickle cell disease · Genetics in Medicine · 2026 · Same journal
• “It didn’t feel like anything unusual because we had already been through so much”: Disability-Related Research Experiences of Families with Children Enrolled in the Undiagnosed Diseases Network · Genetics in Medicine · 2026 · Same journal
• Clinical utility of exome sequencing: Post-exome testing decision changes in the management of children with suspected rare genetic disease · Genetics in Medicine · 2026 · Same journal